DD148235A5 - Verfahren zur herstellung eines ausgewaehlten proteins - Google Patents

Verfahren zur herstellung eines ausgewaehlten proteins Download PDF

Info

Publication number: DD148235A5
Authority: DD; German Democratic Republic
Prior art keywords: protein; gene; selected protein; bacterial; dna
Prior art date: 1978-06-08

Application number

DD79213428A

Other languages

German (de)

English (en)

Inventor

Walter Gilbert

Stephanie A Broome

Lydia J Villa-Komaroff

Argiris A Efstratiadis

Original Assignee

Harvard College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-06-08

Filing date

1979-06-06

Publication date

1981-05-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25433372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD148235(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1979-06-06 Application filed by Harvard College filed Critical Harvard College

1981-05-13 Publication of DD148235A5 publication Critical patent/DD148235A5/de

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 89
102000004169 proteins and genes Human genes 0.000 title claims abstract description 63
238000004519 manufacturing process Methods 0.000 title description 5
238000000034 method Methods 0.000 claims abstract description 30
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 27
108020004414 DNA Proteins 0.000 claims abstract description 23
229940125396 insulin Drugs 0.000 claims abstract description 15
241000894006 Bacteria Species 0.000 claims abstract description 12
108010077805 Bacterial Proteins Proteins 0.000 claims abstract description 12
102000004877 Insulin Human genes 0.000 claims abstract description 12
108090001061 Insulin Proteins 0.000 claims abstract description 12
210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 12
108010078791 Carrier Proteins Proteins 0.000 claims description 18
102000014914 Carrier Proteins Human genes 0.000 claims description 16
108010087702 Penicillinase Proteins 0.000 claims description 16
239000012634 fragment Substances 0.000 claims description 13
241000588724 Escherichia coli Species 0.000 claims description 11
229950009506 penicillinase Drugs 0.000 claims description 11
230000002209 hydrophobic effect Effects 0.000 claims description 9
230000029142 excretion Effects 0.000 claims description 7
230000006798 recombination Effects 0.000 claims description 3
238000005215 recombination Methods 0.000 claims description 3
108020000946 Bacterial DNA Proteins 0.000 claims description 2
OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 claims 1
108010068380 arginylarginine Proteins 0.000 claims 1
238000003776 cleavage reaction Methods 0.000 claims 1
238000010348 incorporation Methods 0.000 claims 1
101150023849 pheA gene Proteins 0.000 claims 1
230000007017 scission Effects 0.000 claims 1
239000013612 plasmid Substances 0.000 abstract description 13
102000053602 DNA Human genes 0.000 abstract description 5
108020004511 Recombinant DNA Proteins 0.000 abstract description 3
241001515965 unidentified phage Species 0.000 abstract description 3
210000004027 cell Anatomy 0.000 description 19
230000001580 bacterial effect Effects 0.000 description 12
150000001413 amino acids Chemical class 0.000 description 11
102000036639 antigens Human genes 0.000 description 10
108091007433 antigens Proteins 0.000 description 10
239000000427 antigen Substances 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
230000000890 antigenic effect Effects 0.000 description 7
239000002299 complementary DNA Substances 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
239000000203 mixture Substances 0.000 description 6
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
241000700605 Viruses Species 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
230000004927 fusion Effects 0.000 description 5
239000002953 phosphate buffered saline Substances 0.000 description 5
239000000047 product Substances 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
229960005486 vaccine Drugs 0.000 description 5
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
241000700159 Rattus Species 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
108010066381 preproinsulin Proteins 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
229920001817 Agar Polymers 0.000 description 3
241000700199 Cavia porcellus Species 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
239000008272 agar Substances 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000001322 periplasm Anatomy 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
229910000160 potassium phosphate Inorganic materials 0.000 description 3
235000011009 potassium phosphates Nutrition 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
239000000523 sample Substances 0.000 description 3
230000009466 transformation Effects 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
229920002554 vinyl polymer Polymers 0.000 description 3
229920000936 Agarose Polymers 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010076181 Proinsulin Proteins 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
230000029087 digestion Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
239000004570 mortar (masonry) Substances 0.000 description 2
230000035772 mutation Effects 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
239000012071 phase Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
229930101283 tetracycline Natural products 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000014616 translation Effects 0.000 description 2
239000013598 vector Substances 0.000 description 2
GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
241000700198 Cavia Species 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
108050001049 Extracellular proteins Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
241000588778 Providencia stuartii Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
238000003916 acid precipitation Methods 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
150000002333 glycines Chemical class 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940079826 hydrogen sulfite Drugs 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000012133 immunoprecipitate Substances 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
238000011587 new zealand white rabbit Methods 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000012216 screening Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
241000894007 species Species 0.000 description 1
229960002385 streptomycin sulfate Drugs 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/30—Signal or leader sequence

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

DD79213428A 1978-06-08 1979-06-06 Verfahren zur herstellung eines ausgewaehlten proteins DD148235A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/913,533 US4411994A (en)	1978-06-08	1978-06-08	Protein synthesis

Publications (1)

Publication Number	Publication Date
DD148235A5 true DD148235A5 (de)	1981-05-13

Family

ID=25433372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD79213428A DD148235A5 (de)	1978-06-08	1979-06-06	Verfahren zur herstellung eines ausgewaehlten proteins

Country Status (20)

Country	Link
US (1)	US4411994A (da)
EP (1)	EP0006694B2 (da)
JP (2)	JPS5519092A (da)
AT (1)	ATE5001T1 (da)
AU (1)	AU524856B2 (da)
BG (1)	BG60444B2 (da)
CA (1)	CA1215920A (da)
DD (1)	DD148235A5 (da)
DE (1)	DE2966291D1 (da)
DK (1)	DK237979A (da)
ES (1)	ES481362A1 (da)
FI (1)	FI791841A7 (da)
GR (1)	GR72953B (da)
IE (1)	IE48156B1 (da)
IL (1)	IL57491A (da)
MX (1)	MX6339E (da)
NZ (1)	NZ190524A (da)
PT (1)	PT69737A (da)
WO (1)	WO1980000030A1 (da)
ZA (1)	ZA792486B (da)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RO80052B (ro) *	1977-11-08	1985-03-30	Genetech	Procedeu pentru prepararea unui vehicul recombinat de clonare pentru transformarea unei gazde bacteriene pentru a deveni generator de polipeptida heterologa
US6268122B1 (en)	1978-12-22	2001-07-31	Biogen, Inc.	Recombinant DNA molecules and their method of production
US4342832A (en) *	1979-07-05	1982-08-03	Genentech, Inc.	Method of constructing a replicable cloning vehicle having quasi-synthetic genes
GR70279B (da) *	1979-09-12	1982-09-03	Univ California
DE3001928A1 (de) *	1980-01-19	1981-08-06	Hoechst Ag, 6000 Frankfurt	Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
US6455275B1 (en)	1980-02-25	2002-09-24	The Trustees Of Columbia University In The City Of New York	DNA construct for producing proteinaceous materials in eucaryotic cells
CA1200773A (en) *	1980-02-29	1986-02-18	William J. Rutter	Expression linkers
AU545912B2 (en) *	1980-03-10	1985-08-08	Cetus Corporation	Cloned heterologous jive products in bacillies
US4711843A (en) *	1980-12-31	1987-12-08	Cetus Corporation	Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis
DK170476B1 (da)	1980-04-03	1995-09-11	Biogen Inc	Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
US4338397A (en) *	1980-04-11	1982-07-06	President And Fellows Of Harvard College	Mature protein synthesis
US6610830B1 (en)	1980-07-01	2003-08-26	Hoffman-La Roche Inc.	Microbial production of mature human leukocyte interferons
NZ198445A (en) *	1980-09-25	1984-05-31	Genentech Inc	Production of human fibroblast interferon by recombinant dna technology
US4394443A (en) *	1980-12-18	1983-07-19	Yale University	Method for cloning genes
FI64813C (fi) *	1980-12-31	1984-01-10	Ilkka Antero Palva	Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
DK582381A (da) *	1981-01-02	1982-07-03	Univ New York	Remkombinat plasmid til anvendelse ved bakteriel kloning
NZ199391A (en) *	1981-01-02	1985-12-13	Genentech Inc	Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US4663285A (en) *	1981-01-06	1987-05-05	The Public Health Laboratory Service Board	Chimeric plasmids
ZA824218B (en) *	1981-06-29	1983-04-27	Cetus Corp	Plasmid for producing human insulin
JPS5869897A (ja) *	1981-10-20	1983-04-26	Gakuzo Tamura	Ｄｎａ遺伝子
EP0078154A3 (en) *	1981-10-28	1985-01-09	The Regents Of The University Of California	Plasmids and cells for heterologous expression of metallothioneins and processes for producing and using the metallothionein
US4532207A (en) *	1982-03-19	1985-07-30	G. D. Searle & Co.	Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4863855A (en) *	1982-05-14	1989-09-05	The Research Foundation Of State University Of New York	Novel cloning vehicles for polypeptide expression in microbial hosts
JPS592689A (ja) *	1982-06-04	1984-01-09	Handai Biseibutsubiyou Kenkyukai	強力な遺伝子発現能を有する新規レプリコンの作成法
US4595658A (en) *	1982-09-13	1986-06-17	The Rockefeller University	Method for facilitating externalization of proteins synthesized in bacteria
DE3382547D1 (de) *	1983-01-12	1992-05-27	Chiron Corp	Sekretorische expression in eukaryoten.
SE8300693L (sv) *	1983-02-09	1984-08-10	Sven Lofdahl	Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
JPS59162874A (ja) *	1983-03-08	1984-09-13	Rikagaku Kenkyusho	微生物の培養方法
US4962055A (en) *	1983-03-08	1990-10-09	Rikagaku Kenkyusho	Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism
DK138984A (da) *	1983-03-08	1984-09-09	Rikagaku Kenkyusho	Plasmid, fremgangsmaade til fremstilling heraf, mikroorganismer indeholdende samme samt fremgangsmaade til dyrkning af mikroorganismen
US4711844A (en) *	1983-03-09	1987-12-08	Cetus Corporation	Modified signal peptides
US4820642A (en) *	1983-04-04	1989-04-11	The Regents Of The University Of California	Amplified expression vector
JPS60501140A (ja) *	1983-04-22	1985-07-25	アムジエン	酵母による外因性ポリペプチドの分泌
US7198919B1 (en)	1983-04-25	2007-04-03	Genentech, Inc.	Use of alpha factor sequences in yeast expression systems
ATE95236T1 (de) *	1983-04-25	1993-10-15	Chiron Corp	Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
US4663280A (en) *	1983-05-19	1987-05-05	Public Health Research Institute Of The City Of New York	Expression and secretion vectors and method of constructing vectors
GB8314362D0 (en) *	1983-05-24	1983-06-29	Celltech Ltd	Polypeptide and protein products
IL71991A (en)	1983-06-06	1994-05-30	Genentech Inc	Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
FR2549855B1 (fr) *	1983-07-29	1987-03-27	Grp Genie Genetique	Sequence nucleotidique codant pour le peptide signal de la toxine diphterique, vecteur contenant cette sequence nucleotidique, leur application a la transformation de micro-organismes et compositions peptidiques obtenues
JPH0646946B2 (ja) *	1984-03-30	1994-06-22	三菱化成株式会社	蛋白の産生方法
US4695542A (en)	1983-10-04	1987-09-22	Dnax Research Institute Of Molecular And Cellular Biology, Inc.	cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
NZ210501A (en) *	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) *	1983-12-13	1987-10-27	Kiren-Amgen, Inc.	DNA sequences encoding erythropoietin
KR850004274A (ko) *	1983-12-13	1985-07-11	원본미기재	에리트로포이에틴의 제조방법
PH23920A (en) *	1983-12-20	1990-01-23	Cetus Corp	Glucoamylase cdna
IT1185503B (it) *	1984-01-11	1987-11-12	Univ New York	Cloni di odna di eritropietina umana
US4859465A (en) *	1984-04-20	1989-08-22	The Regents Of The University Of California	Vaccine capable of eliciting multivalent antibodies
DK58285D0 (da) *	1984-05-30	1985-02-08	Novo Industri As	Peptider samt fremstilling og anvendelse deraf
US6022950A (en) *	1984-06-07	2000-02-08	Seragen, Inc.	Hybrid molecules having translocation region and cell-binding region
US5668255A (en) *	1984-06-07	1997-09-16	Seragen, Inc.	Hybrid molecules having translocation region and cell-binding region
US4801537A (en) *	1984-06-08	1989-01-31	Genex Corporation	Vector for expression of polypeptides in bacilli
US5672347A (en) *	1984-07-05	1997-09-30	Genentech, Inc.	Tumor necrosis factor antagonists and their use
JPH062074B2 (ja) *	1984-07-27	1994-01-12	國男山根	オリゴペプチドの製法
JP2524695B2 (ja) *	1984-12-26	1996-08-14	湧永製薬株式会社	蛋白質の製造法
JP2524693B2 (ja) *	1984-07-30	1996-08-14	湧永製薬株式会社	蛋白質の製造法
DE3587205T2 (de) *	1984-07-30	1993-08-26	Wakunaga Seiyaku Kk	Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
US5691181A (en) *	1984-08-21	1997-11-25	Celltech Limited	DNA encoding lipase from human gastric mucosal tissue
JPS61268183A (ja) *	1985-05-24	1986-11-27	Wakamoto Pharmaceut Co Ltd	Ｄｎａ，組換体ｄｎａおよびそれらを含む微生物
JP2624470B2 (ja) *	1984-10-02	1997-06-25	バイオジェンインコーポレイテッド	ストレプトアビジン様ポリペプチドの製造
US5272254A (en) *	1984-10-02	1993-12-21	Biogen Inc.	Production of streptavidin-like polypeptides
US4963495A (en) *	1984-10-05	1990-10-16	Genentech, Inc.	Secretion of heterologous proteins
JPH0817702B2 (ja) *	1984-12-28	1996-02-28	理化学研究所	新規プラスミド及びその調製方法並びにそのプラスミドを含有する新規微生物
US5190874A (en) *	1984-12-28	1993-03-02	Rikagaku Kenkyusho	Method for producing penicillinase and xylanase
US4774180A (en) *	1986-02-26	1988-09-27	Massachusetts Institute Of Technology	Construction and application of polyproteins
JP2500311B2 (ja) *	1985-03-19	1996-05-29	工業技術院長	蛋白製造法
JP2620852B2 (ja) *	1985-07-30	1997-06-18	理化学研究所	新規プラスミド及びそれにより形質転換された新規微生物
PH25772A (en) *	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
USH2055H1 (en)	1985-09-20	2002-12-03	Zymogenetics, Inc.	Expression of tissue-type plasminogen activator in bacteria
EP0240550A4 (en) *	1985-09-26	1989-09-19	Genetics Inst	Pulmonary surfactant proteins.
WO1987002061A1 (en) *	1985-10-03	1987-04-09	Biotechnology Research Partners, Ltd.	Novel lipoprotein-based drug-delivery systems
GB8529014D0 (en) *	1985-11-25	1986-01-02	Biogen Nv	Enhanced secretion of heterologous proteins
JPH0669377B2 (ja) *	1985-11-25	1994-09-07	工業技術院長	Ｄｎａ塩基配列およびベクタ−
CA1339757C (en) *	1987-04-16	1998-03-17	Robert F. Halenbeck	Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) *	1987-04-16	1990-05-29	Cetus Corporation	Production of purified, biologically active, bacterially produced recombinant human CSF-1
US5084384A (en) *	1987-04-23	1992-01-28	Monsanto Company	Secretion of insulin-like growth factor-I
US5426036A (en) *	1987-05-05	1995-06-20	Hoechst Aktiengesellschaft	Processes for the preparation of foreign proteins in streptomycetes
US5066792A (en) *	1987-09-04	1991-11-19	Board Of Regents University Of Texas	Gene probe for detection of specific human leukemias
DE68928124T2 (de)	1988-09-02	1997-10-16	Chiron Corp., Emeryville, Calif.	Makrophagenabgeleiteter entzündungsmediator(mip-2)
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
FR2648713B1 (fr) *	1989-06-26	1994-06-10	Commissariat Energie Atomique	Proteines hybrides entre une enzyme extracytoplasmique et une autre proteine, leur procede de preparation, ainsi que leur application comme agent de diagnostic
US7413537B2 (en) *	1989-09-01	2008-08-19	Dyax Corp.	Directed evolution of disulfide-bonded micro-proteins
US5578464A (en) *	1989-10-31	1996-11-26	Schering Corporation	E. coli secretory strains
US5595900A (en) *	1990-02-14	1997-01-21	The Regents Of The University Of Michigan	Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1992006191A1 (en) *	1990-09-28	1992-04-16	Protein Engineering Corporation	Proteinaceous anti-dental plaque agents
DE69233697T2 (de) *	1991-03-01	2008-01-24	Dyax Corp., Cambridge	Verfahren zur Entwicklung von bindenden Mikroproteinen
EP1281770B1 (en)	1993-03-10	2010-03-03	GlaxoSmithKline LLC	Human brain phosphodiesterase and screening method
US5691180A (en) *	1994-06-09	1997-11-25	The Regents Of The University Of Michigan	DNA sequence encoding N-acetyl-galactosamine-transferase
US5807732A (en) *	1995-02-28	1998-09-15	Lowe; John B.	GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferases, DNA sequences encoding the same, method for producing the same and a method of genotyping a person
US5770420A (en) *	1995-09-08	1998-06-23	The Regents Of The University Of Michigan	Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US6087128A (en) *	1998-02-12	2000-07-11	Ndsu Research Foundation	DNA encoding an avian E. coli iss
US7858339B1 (en)	1998-10-28	2010-12-28	Genentech, Inc.	Process for bacterial production of polypeptides
EP1618183B1 (en) *	2003-04-29	2014-11-19	Danisco US Inc.	Novel bacillus 029cel cellulase
WO2004099369A2 (en) *	2003-04-30	2004-11-18	Genencor International, Inc.	Novel bacillus bagcel cellulase
JP4757191B2 (ja) *	2003-04-30	2011-08-24	ジェネンコー・インターナショナル・インク	新規なバチルスｍＨＫｃｅｌセルラーゼ
WO2004101763A2 (en) *	2003-05-12	2004-11-25	Genencor International, Inc.	Novel lipolytic enzyme lip1
WO2004101760A2 (en) *	2003-05-12	2004-11-25	Genencor International, Inc.	Novel lipolytic enzyme elip
WO2004101759A2 (en) *	2003-05-12	2004-11-25	Genencor International, Inc.	Novel lipolytic enzyme lip2
CN112400900A (zh)	2012-03-09	2021-02-26	韦斯塔隆公司	毒肽产生、植物中的肽表达和富含半胱氨酸的肽的组合
WO2021216621A2 (en)	2020-04-20	2021-10-28	Vestaron Corporation	Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
AU2021265277A1 (en)	2020-05-01	2022-12-08	Vestaron Corporation	Insecticidal combinations
KR20230078719A (ko)	2020-09-28	2023-06-02	베스타론 코포레이션	해충 방제용 뮤-디구에톡신-Dc1a 변이형 폴리펩타이드
EP4314025A2 (en)	2021-04-01	2024-02-07	Vestaron Corporation	Av3 mutant polypeptides for pest control
EP4312536A1 (en)	2021-04-01	2024-02-07	Vestaron Corporation	Liposome formulations for pesticide delivery and methods for producing and using the same
EP4440595A1 (en)	2021-11-29	2024-10-09	Ironwood Pharmaceuticals, Inc.	Pharmaceutical compositions for the treatment of visceral pain
WO2023192924A1 (en)	2022-03-30	2023-10-05	Vestaron Corporation	Combinations of av3 mutant polypeptides and bt toxins for pest control
PY2336430A (es)	2022-05-18	2023-11-27	Vestaron Corp	Variantes de péptidos pesticidas actx
WO2023245100A1 (en)	2022-06-17	2023-12-21	Vestaron Corporation	Antimicrobial ncr13 variant peptides
WO2023245169A1 (en)	2022-06-17	2023-12-21	Vestaron Corporation	Antimicrobial peptide combinations
WO2023245128A1 (en)	2022-06-17	2023-12-21	Vestaron Corporation	Antimicrobial peptide
WO2024026406A2 (en)	2022-07-29	2024-02-01	Vestaron Corporation	Next Generation ACTX Peptides
EP4727957A2 (en)	2023-06-16	2026-04-22	Vestaron Corporation	Pvd1 variant polypeptides for pest control
AU2024321251A1 (en)	2023-08-04	2026-02-12	Vestaron Corporation	Delta-amaurobitoxin pl1c variant polypeptides for pest control
WO2025226701A1 (en)	2024-04-23	2025-10-30	Vestaron Corporation	Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
WO2026050206A1 (en)	2024-08-27	2026-03-05	Ironwood Pharmaceuticals, Inc.	Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1521032A (en)	1974-08-08	1978-08-09	Ici Ltd	Biological treatment
US4082613A (en) *	1976-04-23	1978-04-04	The Regents Of The University Of Minnesota	Process for the production of insulin by genetically transformed fungal cells
US4190495A (en)	1976-09-27	1980-02-26	Research Corporation	Modified microorganisms and method of preparing and using same
JPS53137215A (en) *	1977-05-06	1978-11-30	Harima Refractories Co Ltd	Reparing material of blast oven gate by spray method
GB2008123B (en) *	1977-11-08	1982-09-08	Genentech Inc	Method of means for microbial polypeptide expression
JPS54163600A (en) *	1977-11-08	1979-12-26	Genentech Inc	Microbiological polypeptide expression method and means
FI792481A7 (fi)	1978-08-11	1981-01-01	The Regents Of The Univ Of	Enkaroyyttisen proteiinin synteesi mikro-organismia käyttäen.
GB2033905B (en)	1978-08-21	1982-10-13	Upjohn Co	Bacterial preparation of proteins

1978
- 1978-06-08 US US05/913,533 patent/US4411994A/en not_active Expired - Lifetime
1979
- 1979-05-02 ZA ZA792486A patent/ZA792486B/xx unknown
- 1979-05-22 NZ NZ190524A patent/NZ190524A/xx unknown
- 1979-05-24 GR GR59168A patent/GR72953B/el unknown
- 1979-06-04 JP JP6901879A patent/JPS5519092A/ja active Granted
- 1979-06-04 DE DE7979301054T patent/DE2966291D1/de not_active Expired
- 1979-06-04 EP EP79301054A patent/EP0006694B2/en not_active Expired - Lifetime
- 1979-06-04 AT AT79301054T patent/ATE5001T1/de active
- 1979-06-05 AU AU47752/79A patent/AU524856B2/en not_active Ceased
- 1979-06-06 DD DD79213428A patent/DD148235A5/de unknown
- 1979-06-06 PT PT69737A patent/PT69737A/pt unknown
- 1979-06-06 IL IL57491A patent/IL57491A/xx unknown
- 1979-06-07 DK DK237979A patent/DK237979A/da not_active Application Discontinuation
- 1979-06-07 ES ES481362A patent/ES481362A1/es not_active Expired
- 1979-06-07 WO PCT/US1979/000399 patent/WO1980000030A1/en not_active Ceased
- 1979-06-07 MX MX798053U patent/MX6339E/es unknown
- 1979-06-08 FI FI791841A patent/FI791841A7/fi not_active Application Discontinuation
- 1979-06-08 CA CA000329373A patent/CA1215920A/en not_active Expired
- 1979-08-08 IE IE1115/79A patent/IE48156B1/en unknown
1986
- 1986-03-26 JP JP61066115A patent/JPH0755151B2/ja not_active Expired - Lifetime
1994
- 1994-02-11 BG BG098458A patent/BG60444B2/bg unknown

Also Published As

Publication number	Publication date
MX6339E (es)	1985-04-23
FI791841A7 (fi)	1981-01-01
EP0006694A2 (en)	1980-01-09
US4411994A (en)	1983-10-25
JPS61227598A (ja)	1986-10-09
GR72953B (da)	1984-01-18
DE2966291D1 (en)	1983-11-17
DK237979A (da)	1979-12-09
ATE5001T1 (de)	1983-10-15
EP0006694A3 (en)	1980-01-23
IE791115L (en)	1979-12-08
AU524856B2 (en)	1982-10-07
ZA792486B (en)	1981-01-28
IE48156B1 (en)	1984-10-17
CA1215920A (en)	1986-12-30
JPS6246160B2 (da)	1987-09-30
AU4775279A (en)	1979-12-13
IL57491A0 (en)	1979-10-31
IL57491A (en)	1983-09-30
EP0006694B1 (en)	1983-10-12
PT69737A (en)	1979-07-01
JPH0755151B2 (ja)	1995-06-14
JPS5519092A (en)	1980-02-09
NZ190524A (en)	1982-09-14
ES481362A1 (es)	1980-03-01
BG60444B2 (bg)	1995-03-31
EP0006694B2 (en)	1992-01-22
WO1980000030A1 (en)	1980-01-10

Publication	Publication Date	Title
US4411994A (en)	1983-10-25	Protein synthesis
US4565785A (en)	1986-01-21	Recombinant DNA molecule
DE69233008T2 (de)	2004-01-22	Fusionierung von Peptiden und Proteinen mit Thioredoxin und thioredoxin-ähnlichen Molekülen
DE3852304T2 (de)	1995-04-06	Organismus als Träger für "Single Chain Antibody Domain (SCAD)".
DE68929387T2 (de)	2002-08-14	Interleukin-1-Inhibitoren
DE68926895T2 (de)	1997-03-13	Ausscheidung von heterologen Proteinen von E. Coli
DE69230733T3 (de)	2008-05-21	Teil der konstanten region von ige enthaltender impfstoff zur behandlung ige-induzierter allergischer reaktionen
DE69920747T2 (de)	2005-10-06	Methode zur herstellung von rekombinanten zellen
DD147369A5 (de)	1981-04-01	Verfahren zur synthese eines eukaryontischen proteins durch mikroorganismen
EA200100670A1 (ru)	2001-12-24	СПОСОБ ВЫСОКОПРОДУКТИВНОЙ ЭКСПРЕССИИ АКТИВНЫХ ХИМЕРНЫХ БЕЛКОВ РЕЦЕПТОРА ЛИМФОТОКСИНА-b; И ИММУНОГЛОБУЛИНА И ИХ ВЫДЕЛЕНИЕ
DE2933000A1 (de)	1980-04-17	Verfahren zur darstellung einer gencodierung fuer ein ein hohes molekulargewicht aufweisendes protein
DE3650676T2 (de)	1998-09-17	Verfahren und mittel zur sortierung und bestimmung biologischer informationen
EP1111050A2 (de)	2001-06-27	Humanes Procalcitonin, dessen Herstellung und Verwendung
DE3750379T2 (de)	1995-02-23	Varianten des abbaubeschleunigenden Faktors (DAF), hergestellt durch rekombinante DNS-Technologie.
DE68908096T2 (de)	1994-01-13	Derivat des O-Antigens von Streptolysin, seine Herstellung und Verwendungen.
KR910021477A (ko)	1991-12-20	인체 단백질 c의 글리코실화 돌연변이체의 발현을 위한 벡터 및 화합물
DE69223502T2 (de)	1998-07-16	Gen für die glykoprotease aus pasteurella haemolytica
CH666050A5 (de)	1988-06-30	Verfahren zur herstellung von interferon epsilon.
CA2201482A1 (en)	1996-04-18	Novel ectoparasite saliva proteins and apparatus to collect such proteins
Londershausen et al.	1985	Uptake and binding of moulting hormones in crayfish
DE3751757T2 (de)	1996-11-28	Autonom replizierende DNA Fragmente aus Säugerzellen mit Affinität zu DNA bindenden Proteinen
DE4419264A1 (de)	1995-06-22	Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen
DE3686981T2 (de)	1993-07-08	Produktion eines proteins.
DE3783425T2 (de)	1993-05-13	Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
DE69111429T2 (de)	1996-01-11	Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.